Drawing for COOLMPS

USPTO serial 79282292

COOLMPS

Reviewed by CopyMark Law Group

Reg. 6297547Status 700Renewal
Filing date
Status date
Registration date
Mar 23, 2021
Examiner
DUONG, ANGELA GAW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COOLMPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Ho

Charles Ho BYIP LTD.5700 Granite Parkway, Suite 200Plano, TX 75024UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Acids, namely, nucleic acid for laboratory use; Chemical preparations, namely, bases for scientific purposes; diagnostic reagents and preparations, except for medical or veterinary use; metallic oxides; isotopes for industrial purposes; industrial chemicals; diagnostic preparations, other than for medical or veterinary purposes; biochemical catalysts; synthetic resins, unprocessedACTIVE—
005Reagents for gene detection for medical purposes; test reagents for medical genetic characteristics; medical diagnostic reagents; medical diagnostic reagents for the analysis of immune system; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; Biological preparations for medical purposes for the treatment of cancer and genetic diseases; Pharmaceutical preparations for treating cancer and genetic diseases; reagents for gene detection for veterinary purposes; dietetic substances adapted for medical useACTIVE—
009Recorded computer programs for biological data mining; Recorded computer programs for developing bioinformatics database for others; Recorded computer programs for analyzing genome information; laboratory apparatus and instruments, namely, gene analyzers for genome information; gene amplification instrument; laboratory equipment, namely, protein sequence analysis apparatus; nucleic acid sequencers used for analyzing nucleic acids in scientific research; automatic chromatographic apparatus for laboratory use; apparatus and measuring instruments for physical and chemical test and composition analysis; Diagnostic apparatus for the detection of pathogens for laboratory or research use; data processing apparatus; clothing for protection against accidents, irradiation and fireACTIVE—
010Apparatus for DNA and RNA testing for medical purposes; medical apparatus for detecting gene; diagnostic apparatus for medical purposes; Medical recording and diagnostic apparatus for use in medical analysis of cancer, genetic diseases and microbial infectious diseases; Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for detecting tumor cancer and genetic diseases; Medical apparatus and instruments for detecting and treating tumor and cancer; Medical apparatus for the regeneration of stem cells for medical purposes; blood testing apparatus; radiological apparatus for medical purposes; surgical implants comprised of artificial materialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 23, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 18, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 29, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 29, 2021FIMPFINAL DISPOSITION PROCESSED—
Jun 23, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jan 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 23, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 23, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 30, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Nov 27, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Nov 25, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 24, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 24, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2020ALIEASSIGNED TO LIE—
Sep 14, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 8, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 8, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 8, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 15, 2020RFNTREFUSAL PROCESSED BY IB—
Apr 28, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 28, 2020RFRRREFUSAL PROCESSED BY MPU—
Apr 12, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 3, 2020DOCKASSIGNED TO EXAMINER—
Apr 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance